Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy
ABSTRACT: Despite ocular adverse events from immune checkpoint inhibitors being uncommon, they are still important complications to be aware of. We present the case of metastatic melanoma on ipilimumab/nivolumab in a patient who developed immunotherapy complications with delayed diagnosis because th...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Innovative Healthcare Institute
2024-05-01
|
| Col·lecció: | Journal of Immunotherapy and Precision Oncology |
| Matèries: | |
| Accés en línia: | https://jipo.org/doi/pdf/10.36401/JIPO-23-44 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|